K
Karyopharm Therapeutics D
D
KPTI
6.31000
USD
0.42
(7.13%)
مغلق
حجم التداول
0
الربح لكل سهم
-3
العائد الربحي
-
P/E
-0
حجم السوق
115,750,438
المقالات
العنوان: Karyopharm Therapeutics Inc.
القطاع: Healthcare
الصناعة: Biotechnology
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).